SEC Filing Summary: Houston American Energy Corp.
Business Context and Reporting Period
This Form 8-K was filed by Houston American Energy Corp. (not Abundia Global Impact Group, Inc.) on September 27, 2016, reporting events occurring on September 26, 2016. The filing addresses a regulatory notice regarding the company's continued listing status on the NYSE MKT.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. It references non-compliance with listing standards requiring stockholders' equity of at least $6.0 million due to reported losses, but does not state the current equity balance.
Material Changes and Listing Status
- Non-Compliance Notice: The company received a Deficiency Letter from NYSE MKT LLC for failing to meet continued listing standards.
- Specific Violations: Non-compliance with Section 1003(a)(iii) (stockholders' equity requirements for companies with losses) and Section 1003(f)(v) (stock price requirements).
- Failed Cure Period: The company failed to demonstrate sustained price improvement or effect a reverse stock split by the September 19, 2016 deadline.
- Extension Granted: NYSE Regulation granted an extension to cure the stock price deficiency through January 3, 2017.
Outlook, Risks, and Contingencies
The primary risk is potential delisting. If the company fails to comply with continued listing standards by January 3, 2017, or fails to make progress consistent with its plan, NYSE Regulation may initiate delisting proceedings. Management has issued a press release acknowledging the notice.
Investor Verification Checklist
- Verify the company's current stockholders' equity balance to assess compliance with the $6.0 million threshold.
- Monitor the stock price trajectory to determine if the January 3, 2017 cure deadline will be met.
- Review the attached press release (Exhibit 99.1) for management's specific plan to regain compliance.
- Confirm whether the company intends to pursue a reverse stock split as an alternative cure method.